| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | 0.0027 | 0.9 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | -0.0023 | 0.9 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.0024 | 0.9 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | 0.0056 | 1 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.0027 | 1 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | methylstat | CTRPv2 | pan-cancer | AAC | 0.0023 | 1 |